DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Evaluation of Ovarian Reserve, Aging and Fertility Preservation in Women With Sickle Cell Disease
In this clinical research study, we aim to understand more about fertility in women with sickle cell disease (SCD). Little data exists on how the disease process may affect ovarian function. This study aims to learn more about how SCD and its treatments affect female fertility and reproduction. We want to evaluate fertility over time and optimize fertility preservation options in women affected by SCD.
Who Is Eligible to Participate?
• Females between ages 18-42.
• Diagnosed with SCD or Sickle Cell Trait.
Related Content
-
news & eventsMARAC Statement: Crizanlizumab (Adakveo)July 7, 2023 - SCDAA’s Medical and Res...
-
education & researchA survey of sickle cell patients transitioned to adult care from Texas children’s hematology center between Januar...An estimated 93-98% of sickle cell disea...
-
education & researchProspective study of sickle cell trait and venous thromboembolism incidenceBACKGROUND: Sickle cell trait may incre...
-
people & placesSickle Cell Clinic at MLK JrThe outpatient sickle cell clinic at MLK...
-
news & eventsCamp New Hope 2022Camp New Hope is a seven-day; six-night ...
-
news & eventsEmmaus, a leader in sickle cell disease treatment, signs agreement with McKesson to expand distribution network for ...Emmaus Life Sciences, Inc., anno...
-
videos & visualsHow to Talk to Your Child About Hydroxyureahttps://www.youtube.com/watch?v=_apTt2j0...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.